États-Unis · Plateformes & données · MarketBeat

HC Wainwright Issues Positive Forecast for Spyglass Pharma (NASDAQ:SGP) Stock Price

Publié par MarketBeat · États-Unis il y a 41 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

HC Wainwright lifted their price target on shares of Spyglass Pharma from $37.00 to $43.00 and gave the stock a "buy" rating in a research note on Thursday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

HC Wainwright Issues Positive Forecast for Spyglass Pharma (NASDAQ:SGP) Stock Price

Résumé détaillé

À lire aussi

Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum

Should a widow leave her late partner’s home to her stepkids — or cut off contact with them?

Nebius Group (NBIS) Q3 2026 Earnings Call Transcript

High Roller Technologies Inks Agreement with ProphetX to Expand Event Contracts Offering Through ROLR

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Oil prices mixed after Trump says no Iran deal needed: 'We've got their Strait'

HC Wainwright Issues Positive Forecast for Spyglass Pharma (NASDAQ:SGP) Stock Price

Résumé détaillé

Partager

À lire aussi

Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum

Should a widow leave her late partner’s home to her stepkids — or cut off contact with them?

Nebius Group (NBIS) Q3 2026 Earnings Call Transcript

High Roller Technologies Inks Agreement with ProphetX to Expand Event Contracts Offering Through ROLR

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Oil prices mixed after Trump says no Iran deal needed: 'We've got their Strait'